2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors. (27th February 2019)

Record Type:: Journal Article
Title:: 2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors. (27th February 2019)
Main Title:: 2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors
Authors:: Tolcher, A W
Fang, D D
Li, Y
Tang, Y
Ji, J
Wang, H
Karim, R
Rosas, C
Huang, Y
Zhai, Y
Abstract:
Is Part Of:: Annals of oncology. Volume 30(2019)Supplement 1
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 1
Issue Display:: Volume 30, Issue 1 (2019)
Year:: 2019
Volume:: 30
Issue:: 1
Issue Sort Value:: 2019-0030-0001-0000
Page Start:
Page End:
Publication Date:: 2019-02-27
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz027 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12089.xml